BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND POT1, DKFZP586D211, 25913, ENSG00000128513, hPot1, DKFZp586D211
12 results:

  • 1. Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families.
    Fidalgo F; Torrezan GT; Sá BCS; Barros BDF; Moredo LF; Valieris R; de Souza SJ; Duprat JP; Krepischi ACV; Carraro DM
    PLoS One; 2022; 17(1):e0262419. PubMed ID: 35085295
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing.
    Yim J; Koh J; Kim S; Song SG; Bae JM; Yun H; Sung JY; Kim TM; Park SH; Jeon YK
    Am J Surg Pathol; 2022 Apr; 46(4):486-497. PubMed ID: 34980830
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Novel compound heterozygous STN1 variants are associated with Coats Plus syndrome.
    Acharya T; Firth HV; Dugar S; Grammatikopoulos T; Seabra L; Walters A; Crow YJ; Parker APJ
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1708. PubMed ID: 34110109
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive characterisation of intronic mis-splicing mutations in human cancers.
    Jung H; Lee KS; Choi JK
    Oncogene; 2021 Feb; 40(7):1347-1361. PubMed ID: 33420369
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.
    Ishigaki K; Akiyama M; Kanai M; Takahashi A; Kawakami E; Sugishita H; Sakaue S; Matoba N; Low SK; Okada Y; Terao C; Amariuta T; Gazal S; Kochi Y; Horikoshi M; Suzuki K; Ito K; Koyama S; Ozaki K; Niida S; Sakata Y; Sakata Y; Kohno T; Shiraishi K; Momozawa Y; Hirata M; Matsuda K; Ikeda M; Iwata N; Ikegawa S; Kou I; Tanaka T; Nakagawa H; Suzuki A; Hirota T; Tamari M; Chayama K; Miki D; Mori M; Nagayama S; Daigo Y; Miki Y; Katagiri T; Ogawa O; Obara W; Ito H; Yoshida T; Imoto I; Takahashi T; Tanikawa C; Suzuki T; Sinozaki N; Minami S; Yamaguchi H; Asai S; Takahashi Y; Yamaji K; Takahashi K; Fujioka T; Takata R; Yanai H; Masumoto A; Koretsune Y; Kutsumi H; Higashiyama M; Murayama S; Minegishi N; Suzuki K; Tanno K; Shimizu A; Yamaji T; Iwasaki M; Sawada N; Uemura H; Tanaka K; Naito M; Sasaki M; Wakai K; Tsugane S; Yamamoto M; Yamamoto K; Murakami Y; Nakamura Y; Raychaudhuri S; Inazawa J; Yamauchi T; Kadowaki T; Kubo M; Kamatani Y
    Nat Genet; 2020 Jul; 52(7):669-679. PubMed ID: 32514122
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A pot1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.
    Takai H; Jenkinson E; Kabir S; Babul-Hirji R; Najm-Tehrani N; Chitayat DA; Crow YJ; de Lange T
    Genes Dev; 2016 Apr; 30(7):812-26. PubMed ID: 27013236
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Recent developments in brain tumor predisposing syndromes.
    Johansson G; Andersson U; Melin B
    Acta Oncol; 2016; 55(4):401-11. PubMed ID: 26634384
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Telomere maintenance and the etiology of adult glioma.
    Walsh KM; Wiencke JK; Lachance DH; Wiemels JL; Molinaro AM; Eckel-Passow JE; Jenkins RB; Wrensch MR
    Neuro Oncol; 2015 Nov; 17(11):1445-52. PubMed ID: 26014050
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Germline mutations in shelterin complex genes are associated with familial glioma.
    Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
    J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Telomere profiling: toward glioblastoma personalized medicine.
    Ferrandon S; Saultier P; Carras J; Battiston-Montagne P; Alphonse G; Beuve M; Malleval C; Honnorat J; Slatter T; Hung N; Royds J; Rodriguez-Lafrasse C; Poncet D
    Mol Neurobiol; 2013 Feb; 47(1):64-76. PubMed ID: 23065374
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
    Lee JE; Oh BK; Choi J; Park YN
    Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Variation of the 3' telomeric overhang lengths in human cells.
    Lee ME; Rha SY; Jeung HC; Kim TS; Chung HC; Oh BK
    Cancer Lett; 2008 Jun; 264(1):107-18. PubMed ID: 18316158
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.